<DOC>
	<DOCNO>NCT02838381</DOCNO>
	<brief_summary>The aim study characterize genetic cellular immunological parameter metastatic digestive cancer patient short long response chemotherapy .</brief_summary>
	<brief_title>Study Genetic Cellular Immunological Parameters Predictive Disease-free Survival Patients With Metastatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<criteria>For patient : sign write informed consent For cohort A : patient metastatic colorectal cancer firstline therapy chemotherapy +/ surgery diseasefree survival &gt; = 20 month Ctscan realize previous 4 week show progression accord Recist criterion v1.1 For cohort B : patient treat metastatic colorectal cancer chemotherapy responder ( obtention objective response accord Recist criterion V1.1 firstline therapy ) , diseasefree survival &lt; 10 month ( disease progression must confirm CT scan evaluation accord Recist v1.1 criterion ) For cohort C : patient metastatic rectum cancer complete remission chemotherapy and/or radiotherapy For cohort D : patient metastatic locally advanced cancer complete remission treatment , non eligible cohort For patient : patient medical psychiatric condition disease would make patient inappropriate entry study patient neurodegenerative disease patient guardianship , curator protection justice</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>